Inventor · disambiguated record
Bobak Robert Azamian
Also filed as: AZAMIAN BOBAK ROBERT
36 granted patents·24 pending applications·684 citations·filing 2013–2025
98Inventor score
Files withMETAVENTION INC27TARSUS PHARMACEUTICALS INC18MEDTRONIC IRELAND MFG UNLIMITED COMPANY13VIBRATO MEDICAL INC2
Top patents by PatentIndex Score
60 records- 0198US11197847B2Isoxazoline parasiticide formulations and methods for treating blepharitisTARSUS PHARMACEUTICALS INC·Filed 2021·Granted Dec 14, 2021·11 cites·23 claims
- 0298US10856926B2Neuromodulation for metabolic conditions or syndromesMETAVENTION INC·Filed 2018·Granted Dec 8, 2020·10 cites·20 claims
- 0398US10070911B2Neuromodulation methods to alter glucose levelsMETAVENTION INC·Filed 2016·Granted Sep 11, 2018·12 cites·20 claims
- 0498US9089541B2Gastroduodenal artery neuromodulationMETAVENTION INC·Filed 2013·Granted Jul 28, 2015·24 cites·20 claims
- 0598US9005191B2Neuromodulation methods using balloon catheterMETAVENTION INC·Filed 2013·Granted Apr 14, 2015·41 cites·20 claims
- 0698US8876815B2Energy delivery devices for hepatic neuromodulationMETAVENTION INC·Filed 2014·Granted Nov 4, 2014·53 cites·20 claims
- 0798US8579891B2Devices for thermally-induced hepatic neuromodulationMETAVENTION INC·Filed 2013·Granted Nov 12, 2013·31 cites·20 claims
- 0897US11690826B2Methods for treating demodex blepharitis using lotilaner formulationsTARSUS PHARMACEUTICALS INC·Filed 2022·Granted Jul 4, 2023·6 cites·20 claims
- 0997US11690827B2Methods for treating ocular Demodex using lotilaner formulationsTARSUS PHARMACEUTICALS INC·Filed 2022·Granted Jul 4, 2023·6 cites·20 claims
- 1097US9114123B2Hepatic neuromodulation using fluids or chemical agentsMETAVENTION INC·Filed 2014·Granted Aug 25, 2015·41 cites·18 claims
- 1197US9005190B2Treatment of non-alcoholic fatty liver diseaseMETAVENTION INC·Filed 2013·Granted Apr 14, 2015·14 cites·20 claims
- 1296US12364685B2Isoxazoline parasiticide formulationsTARSUS PHARMACEUTICALS INC·Filed 2024·Granted Jul 22, 2025·1 cites·32 claims
- 1396US12213964B2Isoxazoline parasiticide formulationsTARSUS PHARMACEUTICALS INC·Filed 2023·Granted Feb 4, 2025·2 cites·21 claims
- 1496US12171750B2Isoxazoline parasiticide formulations and methods for treating blepharitisTARSUS PHARMACEUTICALS INC·Filed 2023·Granted Dec 24, 2024·2 cites·16 claims
- 1596US11752137B2Ophthalmic compositions for treating ocular Demodex using lotilaner formulationsTARSUS PHARMACEUTICALS INC·Filed 2022·Granted Sep 12, 2023·4 cites·20 claims
- 1696US8758334B2Hepatic neuromodulation devicesMETAVENTION INC·Filed 2013·Granted Jun 24, 2014·72 cites·19 claims
- 1795US10835517B2Methods for treating ocular demodex using isoxazoline parasiticide formulationsTARSUS PHARMACEUTICALS INC·Filed 2018·Granted Nov 17, 2020·12 cites·28 claims
- 1895US9033969B2Nerve modulation to treat diabetesMETAVENTION INC·Filed 2013·Granted May 19, 2015·29 cites·20 claims
- 1995US8568399B2Methods for thermally-induced hepatic neuromodulationMETAVENTION INC·Filed 2013·Granted Oct 29, 2013·65 cites·69 claims
- 2094US10064674B2Methods of modulating nerves of the hepatic plexusMETAVENTION INC·Filed 2015·Granted Sep 4, 2018·10 cites·20 claims
- 2194US9999461B2Therapeutic denervation of nerves surrounding a hepatic vesselMETAVENTION INC·Filed 2015·Granted Jun 19, 2018·12 cites·20 claims
- 2293US10617460B2Neuromodulation for metabolic conditions or syndromesMETAVENTION INC·Filed 2019·Granted Apr 14, 2020·7 cites·20 claims
- 2393US10543034B2Modulation of nerves innervating the liverMETAVENTION INC·Filed 2018·Granted Jan 28, 2020·7 cites·20 claims
- 2493US8894639B2Hepatic artery nerve modulation methodsMETAVENTION INC·Filed 2014·Granted Nov 25, 2014·26 cites·20 claims
- 2593US8728069B2Modulation of nerves that innervate the liverMETAVENTION INC·Filed 2013·Granted May 20, 2014·26 cites·19 claims
- 2693US8728070B2Hepatic neuromodulation methodsMETAVENTION INC·Filed 2013·Granted May 20, 2014·29 cites·20 claims
- 2792US9265575B2Balloon catheter neuromodulation systemsMETAVENTION INC·Filed 2013·Granted Feb 23, 2016·24 cites·20 claims
- 2891US10524859B2Therapeutic tissue modulation devices and methodsMETAVENTION INC·Filed 2017·Granted Jan 7, 2020·18 cites·20 claims
- 2991US9149329B2Glucose alteration methodsMETAVENTION INC·Filed 2013·Granted Oct 6, 2015·19 cites·20 claims
- 3091US9114124B2Modulation of nerves innervating the liverMETAVENTION INC·Filed 2014·Granted Aug 25, 2015·16 cites·20 claims
- 3191US9060784B2Hepatic denervation systemsMETAVENTION INC·Filed 2013·Granted Jun 23, 2015·22 cites·17 claims
- 3291US2025127762A1Isoxazoline parasiticide formulations and methods for treating blepharitisTARSUS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3390US9089542B2Hepatic neuromodulation using microwave energyMETAVENTION INC·Filed 2014·Granted Jul 28, 2015·16 cites·20 claims
- 3490US9011422B2Hepatic neuromodulation to treat fatty liver conditionsMETAVENTION INC·Filed 2014·Granted Apr 21, 2015·14 cites·20 claims
- 3590US2024130774A1Neuromodulation for metabolic conditions or syndromesMEDTRONIC IRELAND MFG UNLIMITED COMPANY·Filed 2023·Application pending·0 cites
- 3690US2024138896A1Neuromodulation for metabolic conditions or syndromesMEDTRONIC IRELAND MFG UNLIMITED COMPANY·Filed 2023·Application pending·0 cites
- 3790US2024206939A1Neuromodulation for metabolic conditions or syndromesMEDTRONIC IRELAND MFG UNLIMITED COMPANY·Filed 2024·Application pending·0 cites
- 3890US2024173062A1Neuromodulation for metabolic conditions or syndromesMEDTRONIC IRELAND MFG UNLIMITED COMPANY·Filed 2023·Application pending·0 cites
- 3990US2024130773A1Neuromodulation for metabolic conditions or syndromesMEDTRONIC IRELAND MFG UNLIMITED COMPANY·Filed 2023·Application pending·0 cites
- 4090US2024173061A1Neuromodulation for metabolic conditions or syndromesMEDTRONIC IRELAND MFG UNLIMITED COMPANY·Filed 2023·Application pending·0 cites
- 4190US2024130772A1Neuromodulation for metabolic conditions or syndromesMEDTRONIC IRELAND MFG UNLIMITED COMPANY·Filed 2023·Application pending·0 cites
- 4288US12029466B2Neuromodulation for metabolic conditions or syndromesMEDTRONIC IRELAND MFG UNLIMITED COMPANY·Filed 2020·Granted Jul 9, 2024·1 cites·20 claims
- 4388US2025312317A1Isoxazoline parasiticide formulations and methods for treating blepharitisTARSUS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 4488US2025312318A1Isoxazoline parasiticide formulations and methods for treating blepharitisTARSUS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 4586US2023190711A1Methods for treating ocular demodex using spinosad formulationsTARSUS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 4686US2024325079A1Modulation of targeted nerve fibersMEDTRONIC IRELAND MFG UNLIMITED COMPANY·Filed 2024·Application pending·0 cites
- 4786US2024325078A1Modulation of targeted nerve fibersMEDTRONIC IRELAND MFG UNLIMITED COMPANY·Filed 2024·Application pending·0 cites
- 4885US2024261017A1Modulation of targeted nerve fibersMEDTRONIC IRELAND MFG UNLIMITED COMPANY·Filed 2024·Application pending·0 cites
- 4985US2024261016A1Modulation of targeted nerve fibersMEDTRONIC IRELAND MFG UNLIMITED COMPANY·Filed 2024·Application pending·0 cites
- 5077US12011212B2Modulation of targeted nerve fibersMEDTRONIC IRELAND MFG UNLIMITED COMPANY·Filed 2019·Granted Jun 18, 2024·1 cites·20 claims
Showing the top 50 of 60 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Bobak Robert Azamian files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →